Sono-Tek (SOTK) 10-K 23 May 24 2024 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Feb. 29, 2024	May 17, 2024	Aug. 31, 2023
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Feb. 29, 2024
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--02-28
Entity File Number	000-16035
Entity Registrant Name	SONO TEK CORP
Entity Central Index Key	0000806172
Entity Tax Identification Number	14-1568099
Entity Incorporation, State or Country Code	NY
Entity Address, Address Line One	2012 Route 9W
Entity Address, City or Town	Milton
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	12547
City Area Code	(845)
Local Phone Number	795-2020
Title of 12(b) Security	Common Stock $0.01 par value
Trading Symbol	SOTK
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 72,065,185
Entity Common Stock, Shares Outstanding		15,750,880
Documents Incorporated by Reference [Text Block]	None.
ICFR Auditor Attestation Flag	false
Document Financial Statement Error Correction [Flag]	false
Auditor Firm ID	688
Auditor Name	Marcum LLP
Auditor Location	East Hanover, NJ

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Feb. 29, 2024	Feb. 28, 2023
Current Assets:
Cash and cash equivalents	$ 2,134,786	$ 3,354,601
Marketable securities	9,711,351	8,090,000
Accounts receivable (less allowance of $12,225)	1,470,711	1,633,866
Inventories	5,221,980	3,242,909
Prepaid expenses and other current assets	207,738	254,046
Total current assets	18,746,566	16,575,422
Land	250,000	250,000
Buildings, equipment, furnishings and leasehold improvements, net	2,832,156	2,624,996
Intangible assets, net	47,566	57,202
Deferred tax asset	1,255,977	667,098
TOTAL ASSETS	23,132,265	20,174,718
Current Liabilities:
Accounts payable	1,049,742	810,863
Accrued expenses	1,739,478	1,427,446
Customer deposits	3,419,706	2,838,165
Income taxes payable	414,807	381,421
Total current liabilities	6,623,733	5,457,895
Deferred tax liability	229,534	82,865
Total Liabilities	6,853,267	5,540,760
Stockholders’ Equity
Common stock, $.01 par value; 25,000,000 shares authorized, 15,750,880 and 15,742,073 issued and outstanding as of February 29, 2024, and February 28, 2023, respectively	157,509	157,421
Additional paid-in capital	9,770,387	9,566,898
Accumulated earnings	6,351,102	4,909,639
Total stockholders’ equity	16,278,998	14,633,958
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 23,132,265	$ 20,174,718

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Feb. 29, 2024	Feb. 28, 2023
Statement of Financial Position [Abstract]
Allowance for doubtful accounts receivable	$ 12,225	$ 12,225
Common stock, par value	$ 0.01	$ 0.01
Common stock, authorized	25,000,000	25,000,000
Common stock, issued shares	15,750,880	15,742,073
Common stock, outstanding shares	15,750,880	15,742,073

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME - USD ($)	12 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Income Statement [Abstract]
Net Sales	$ 19,699,886	$ 15,058,203
Cost of Goods Sold	9,855,311	7,406,196
Gross Profit	9,844,575	7,652,007
Operating Expenses
Research and product development	2,885,773	2,149,525
Marketing and selling	3,695,870	3,169,730
General and administrative	2,080,447	1,649,761
Total Operating Expenses	8,662,090	6,969,016
Operating Income	1,182,485	682,991
Other Income (Expense):
Interest and Dividend Income	529,735	140,042
Net unrealized gain/(loss) on marketable securities	32,360	(33,119)
Income before Income Taxes	1,744,580	789,914
Income Tax Expense	303,117	154,009
Net Income	$ 1,441,463	$ 635,905
Basic Earnings Per Share	$ 0.09	$ 0.04
Diluted Earnings Per Share	$ 0.09	$ 0.04
Weighted Average Shares – Basic	15,743,763	15,735,451
Weighted Average Shares – Diluted	15,774,007	15,769,499

ONSOLIDATED STATEMENTS OF STOCK

ONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance - February 28, 2023 at Feb. 28, 2022	$ 157,292	$ 9,310,287	$ 4,273,734	$ 13,741,313
Beginning balance, shares at Feb. 28, 2022	15,729,175
Stock based compensation expense		256,740		256,740
Cashless exercise of stock options	$ 129	(129)
Cashless exercise of stock options, shares	12,898
Net Income			635,905	635,905
Balance - February 29, 2024 at Feb. 28, 2023	$ 157,421	9,566,898	4,909,639	14,633,958
Ending balance, shares at Feb. 28, 2023	15,742,073
Stock based compensation expense		203,577		203,577
Cashless exercise of stock options	$ 88	(88)
Cashless exercise of stock options, shares	8,807
Net Income			1,441,463	1,441,463
Balance - February 29, 2024 at Feb. 29, 2024	$ 157,509	$ 9,770,387	$ 6,351,102	$ 16,278,998
Ending balance, shares at Feb. 29, 2024	15,750,880

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income	$ 1,441,463	$ 635,905
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	597,166	510,868
Stock based compensation expense	203,577	256,740
Accounts receivable reserve		(43,898)
Inventory reserve	47,875	4,864
Unrealized (gain) loss on marketable securities	(32,360)	33,119
Deferred tax asset, net	(442,210)	(512,337)
(Increase) Decrease in:
Accounts receivable	163,155	(497,463)
Inventories	(2,026,946)	(874,531)
Prepaid expenses and other assets	46,308	69,258
(Decrease) Increase in:
Accounts payable	238,879	126,352
Accrued expenses	312,032	(376,582)
Customer deposits	581,541	1,670,197
Income taxes payable	33,386	322,547
Net Cash Provided by Operating Activities	1,163,866	1,325,039
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment, furnishings and leasehold improvements	(794,690)	(555,867)
Sale of marketable securities	20,237,051	14,329,159
Purchase of marketable securities	(21,826,042)	(16,584,288)
Net Cash Used In Investing Activities	(2,383,681)	(2,810,996)
NET (DECREASE) IN CASH AND CASH EQUIVALENTS	(1,219,815)	(1,485,957)
CASH AND CASH EQUIVALENTS:
Beginning of year	3,354,601	4,840,558
End of year	2,134,786	3,354,601
Supplemental Cash Flow Disclosure:
Interest Paid
Income Taxes Paid	$ 712,092	$ 363,590

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Feb. 29, 2024
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

BUSINESS DESCRIPTION

BUSINESS DESCRIPTION	12 Months Ended
	Feb. 29, 2024
Accounting Policies [Abstract]
BUSINESS DESCRIPTION	NOTE 1: BUSINESS DESCRIPTION Sono-Tek Corporation (the “Company”, “Sono-Tek”, “We” or “Our”) was incorporated in New York on March 21, 1975. We are the world leader in the design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. We design and manufacture custom-engineered ultrasonic coating systems incorporating our patented technology, in combination with strong applications engineering knowledge, to assist our customers in achieving their desired coating solutions.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Feb. 29, 2024
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	NOTE 2: SIGNIFICANT ACCOUNTING POLICIES Advertising Expenses - 371,000 297,500 Accounts Receivable, net Cash and Cash Equivalents - 1,819,000 Consolidation Earnings Per Share - Equipment, Furnishings and Leasehold Improvements 3 5 Fair Value of Financial Instruments Fair Value Measurement The carrying amounts of financial instruments reported in the accompanying consolidated financial statements for current assets and current liabilities approximate the fair value because of the immediate or short-term maturities of the financial instruments. The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below: Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. The fair values of financial assets of the Company were determined using the following categories at February 29, 2024 and February 28, 2023, respectively: Schedule of significant accounting policies - fair values of financial assets of the company Level 1 Level 2 Level 3 Total Marketable Securities – February 29, 2024 $ 9,711,351 $ — $ — $ 9,711,351 Marketable Securities – February 28, 2023 $ 7,361,000 $ 729,000 $ — $ 8,090,000 Marketable Securities include certificates of deposit and US Treasury securities, totaling $ 9,711,351 8,090,000 Income Taxes no Intangible Assets - 17 12 16,434 18,814 212,861 202,681 16,000 Inventories - Land and Buildings 40 At February 29, 2024 and February 28, 2023, the Company had Land, stated at cost of $ 250,000 Long-Lived Assets - No Management Estimates - New Accounting Pronouncements Recent Accounting Pronouncements Not Yet Adopted Improvements to Income Tax Disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting Product Warranty Research and Product Development Expenses - During fiscal 2024 and fiscal 2023, the Company spent approximately $ 2,886,000 2,149,000 Revenue Recognition · Identification of the contract, or contracts, with a customer · Identification of the performance obligations in the contract · Determination of the transaction price · Allocation of the transaction price to the performance obligations in the contract · Recognition of revenue when, or as, performance obligations are satisfied Stock-Based Compensation ASC 718 requires the recognition of the fair value of stock compensation expense to be recognized over the vesting term of such award. The Company accounts for forfeitures as they occur.

REVENUE RECOGNITION

REVENUE RECOGNITION	12 Months Ended
	Feb. 29, 2024
Revenue Recognition
REVENUE RECOGNITION	NOTE 3: REVENUE RECOGNITION The Company’s sales revenue is derived primarily from short term contracts with customers, which, on average, are in effect for less than twelve months. Sales revenue from manufactured equipment transferred at a single point in time accounts for a majority of the Company’s revenue. Sales revenue is recognized when control of the Company’s manufactured equipment is transferred to its customers in an amount that reflects the consideration the Company expects to receive based upon the agreed transaction price. The Company’s performance obligations are satisfied when its customers take control of the purchased equipment, in accordance with the contract terms. Based on prior experience, the Company reasonably estimates its sales returns and warranty reserves. Sales are presented net of discounts and allowances. Discounts and allowances are determined when a transaction is negotiated. The Company does not grant its customers or independent representatives the ability to return equipment nor does it grant price adjustments after a sale is complete. The Company does not capitalize any sales commission costs related to the acquisition of a contract. All commissions related to a performance obligation that are satisfied at a point in time are expensed when the customer takes control of the purchased equipment and revenue is recognized. The Company applies the practical expedient in paragraph ASC 606-10-50-14 and does not disclose information about remaining performance obligations that have original expected durations of one-year or less. At February 29, 2024, the Company had received $ 3,420,000 72,000 72,000 At February 28, 2023, the Company had received $ 2,838,000 145,000 145,000 The Company’s sales revenue, by product line is as follows: Schedule of revenue recognition - sales revenue by product line Twelve Months Ended February 29, February 28, 2024 % of total 2023 % of total Fluxing Systems $ 724,000 4% $ 1,179,000 8% Integrated Coating Systems 2,889,000 14% 1,114,000 7% Multi-Axis Coating Systems 10,075,000 51% 6,785,000 45% OEM Systems 1,533,000 8% 2,144,000 14% Other 4,479,000 23% 3,836,000 26% TOTAL $ 19,700,000 $ 15,058,000

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	12 Months Ended
	Feb. 29, 2024
Equity [Abstract]
STOCK-BASED COMPENSATION	NOTE 4: STOCK-BASED COMPENSATION Stock Options 2,500,000 65,793 229,749 Under the 2023 Stock Incentive Plan, as amended (the "2023 Plan"), options can be granted to officers, directors, consultants and employees of the Company and its subsidiaries to purchase up to 2,500,000 10 During fiscal 2024, the Company granted options to acquire 54,813 4.79 5.60 18,380 4.79 3 10 3.11 During fiscal 2023, the Company granted options to acquire 28,239 5.45 5.96 16,500 5.50 3 10 3.44 A summary of the activity for both plans, for fiscal 2024 and fiscal 2023 is as follows: Stock-based compensation - summary of stock options Weighted Average Stock Options Exercise Price $ Remaining Outstanding Exercisable Outstanding Exercisable Term - Years Balance - February 28, 2022 253,710 61,690 $ 4.46 $ 3.53 8.94 Granted 44,739 5.71 Exercised (16,973 ) (1.77 ) Cancelled (30,717 ) (4.66 ) Balance - February 28, 2023 250,759 133,609 $ 4.84 $ 4.62 8.52 Granted 73,193 $ 5.02 Exercised (19,701 ) (3.62 ) Cancelled (8,709 ) (4.20 ) Balance - February 29, 2024 295,542 181,376 $ 4.99 $ 4.89 8.04 The aggregate intrinsic value of the Company’s vested and exercisable options at February 29, 2024 was $ 167,709 For the years ended February 29, 2024 and February 28, 2023 the Company recognized $ 203,577 256,740 298,000 3 8,807 Determining the appropriate fair value of the stock-based awards requires the input of subjective assumptions, including the fair value of the Company’s common stock, and for stock options, the expected life of the option, and the expected stock price volatility. The Company uses the Black-Scholes option pricing model to value its stock option awards. The assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment. The expected term of the options is estimated based on the Company’s historical exercise rate. The expected life of awards that vest immediately use the contractual maturity since they are vested when issued. For stock price volatility, the Company uses its expected volatility of the price of the Company’s common stock based on historical activity. The risk-free interest rate is based on U.S. Treasury notes with a term approximating the expected life of the option at the grant-date. The weighted-average fair value of options has been estimated on the date of grant using the Black-Scholes options-pricing model. The weighted-average Black-Scholes assumptions are as follows: Schedule of weighted-average black-scholes assumptions Fiscal Year Ended February 29, February 28, Expected life 5 8 5 8 Risk free interest rate 2.82% 4.39% 2.82% 4.02% Expected volatility 55.02% 62.48% 55.02% 62.01% Expected dividend yield 0% 0%

INVENTORIES

INVENTORIES	12 Months Ended
	Feb. 29, 2024
Inventory Disclosure [Abstract]
INVENTORIES	NOTE 5: INVENTORIES Inventories consist of the following: Schedule of inventory, current February 29, February 28, Raw materials and subassemblies $ 2,270,567 $ 1,868,689 Finished goods 1,785,952 613,915 Work in process 1,165,461 760,305 Total $ 5,221,980 $ 3,242,909 The Company maintains an allowance for slow-moving inventory for raw materials and finished goods. The recorded allowances at February 29, 2024 and February 28, 2023, totaled $ 380,400 332,525

BUILDINGS, EQUIPMENT, FURNISHIN

BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS	12 Months Ended
	Feb. 29, 2024
Property, Plant and Equipment [Abstract]
BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS	NOTE 6: BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS Buildings, equipment, furnishings and leasehold improvements consist of the following: Buildings, equipment, furnishings and leasehold improvements February 29, February 28, 2024 2023 Buildings $ 2,250,000 $ 2,250,000 Laboratory equipment 1,733,911 1,647,951 Machinery and equipment 1,891,345 1,807,817 Leasehold improvements 924,356 789,044 Tradeshow and demonstration equipment 1,151,899 1,137,346 Furniture and fixtures 1,771,084 1,302,545 Totals 9,722,595 8,934,703 Less: Accumulated depreciation (6,890,439 ) (6,309,707 ) $ 2,832,156 $ 2,624,996 Depreciation expense for the years ended February 29, 2024 and February 28, 2023 was $ 580,732 492,055

ACCRUED EXPENSES

ACCRUED EXPENSES	12 Months Ended
	Feb. 29, 2024
Payables and Accruals [Abstract]
ACCRUED EXPENSES	NOTE 7: ACCRUED EXPENSES Accrued expenses consist of the following: Accrued expenses February 29, February 28, Accrued compensation $ 579,757 $ 352,619 Estimated warranty costs 524,875 500,650 Accrued sales tax 152,547 — Accrued commissions 133,771 157,927 Professional fees 74,826 100,921 Other accrued expenses 273,702 315,329 Total accrued expenses $ 1,739,478 $ 1,427,446

REVOLVING LINE OF CREDIT

REVOLVING LINE OF CREDIT	12 Months Ended
	Feb. 29, 2024
Debt Disclosure [Abstract]
REVOLVING LINE OF CREDIT	NOTE 8: REVOLVING LINE OF CREDIT The Company has a $ 1,500,000 8.50% 7.75% As of February 29, 2024, $ 72,000 1,428,000 As of February 28, 2023, $ 145,000 1,355,000

INCOME TAXES

INCOME TAXES	12 Months Ended
	Feb. 29, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 9: INCOME TAXES The annual provision (benefit) for income taxes differs from amounts computed by applying the maximum U.S. Federal income tax rate of 21% to pre-tax income as follows: Income taxes - income tax reconciliation February 29, February 28, Expected federal income tax $ 366,362 $ 165,882 State tax, net of federal 52,510 37,204 Research and development tax credits (161,525 ) (127,329 ) Permanent differences 45,770 78,252 Income tax expense $ 303,117 $ 154,009 Components of the current and deferred tax expense are as follows: Income taxes - current and deferred tax expense February 29, February 28, Current: Federal $ 716,003 $ 438,263 State 123,743 83,525 Total current income tax 839,746 521,788 Deferred: Federal (471,396 ) (321,458 ) State (65,233 ) (46,321 ) Total deferred income tax (536,629 ) (367,779 ) Income tax expense $ 303,117 $ 154,009 In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and projections for future taxable income over periods in which the deferred tax assets are deductible. Management believes it is more likely than not that the Company will realize the benefits of these deductible differences. The incorporation of the new tax laws for 2023, requires the Company to capitalize for income tax purposes research and development expenses incurred during the year and for such expenses to be amortized over a five year period. As a result, a deferred tax asset “Capitalized R&D expenses – IRC Section 174” has been recorded. The Company does not have any uncertain tax positions in 2024. There are no interest and penalties related to uncertain tax positions in 2024. As of February 29, 2024, open years related to the federal and state jurisdictions are 2023, 2022 and 2021. The deferred tax asset and liability are comprised of the following: Income taxes - deferred tax asset and liability components February 29, February 28, Deferred tax asset Allowance for inventory $ 91,000 $ 76,000 Allowance for accounts receivable 3,000 3,000 Capitalized R&D expenses – IRC Section 174 985,000 441,000 Accrued expenses and other 177,000 147,000 Deferred tax asset – Long Term $ 1,256,000 $ 667,000 Deferred tax liability Building and leasehold depreciation (230,000 ) (83,000 ) Deferred tax liability – Long Term $ (230,000 ) $ (83,000 )

EARNINGS PER SHARE

EARNINGS PER SHARE	12 Months Ended
	Feb. 29, 2024
Earnings Per Share [Abstract]
EARNINGS PER SHARE	NOTE 10: EARNINGS PER SHARE The following table sets forth the computation of basic and diluted earnings per share: Schedule of computation of basic and diluted earnings per share February 29, February 28, Numerator for basic and diluted earnings per share $ 1,441,463 $ 635,905 Denominator for basic earnings per share - weighted average 15,743,763 15,735,451 Effects of dilutive securities: Stock options for employees, directors and outside consultants 30,244 34,048 Denominator for diluted earnings per share 15,774,007 15,769,499 Basic Earnings Per Share – Weighted Average $ 0.09 $ 0.04 Diluted Earnings Per Share – Weighted Average $ 0.09 $ 0.04

CUSTOMER CONCENTRATIONS AND FOR

CUSTOMER CONCENTRATIONS AND FOREIGN SALES	12 Months Ended
	Feb. 29, 2024
Risks and Uncertainties [Abstract]
CUSTOMER CONCENTRATIONS AND FOREIGN SALES	NOTE 11: CUSTOMER CONCENTRATIONS AND FOREIGN SALES Export sales to customers located outside the United States and Canada were approximately as follows: Schedule of customer concentrations and foreign sales February 29, February 28, Asia Pacific (APAC) 3,268,000 3,260,000 Europe, Middle East, Asia (EMEA) 4,333,000 3,448,000 Latin America 1,221,000 1,546,000 $ 8,822,000 $ 8,254,000 During fiscal 2024 and fiscal 2023, sales to foreign customers accounted for approximately $ 8,822,000 8,254,000 45% 55% For the fiscal years ended February 29, 2024 and February 28, 2023, no single customer accounted for more than 10% of the Company’s revenues. Two customers accounted for 26 Two customers accounted for 28 The Company had two customers which accounted for 14% 44%

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Feb. 29, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 12: COMMITMENTS AND CONTINGENCIES Other than the letters of credit discussed in Notes 3 and 8, the Company did not have any material commitments or contingencies as of February 29, 2024. The Company is subject, from time to time, to claims by third parties under various legal disputes. The defense of such claims, or any adverse outcome relating to any such claims, could have a material adverse effect on the Company’s liquidity, financial condition, and cash flows. As of February 29, 2024, the Company did not have any pending legal actions.

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Feb. 29, 2024
Accounting Policies [Abstract]
Advertising Expenses	Advertising Expenses - 371,000 297,500
Accounts Receivable, net	Accounts Receivable, net
Cash and Cash Equivalents	Cash and Cash Equivalents - 1,819,000
Consolidation	Consolidation
Earnings Per Share	Earnings Per Share -
Equipment, Furnishings and Leasehold Improvements	Equipment, Furnishings and Leasehold Improvements 3 5
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value Measurement The carrying amounts of financial instruments reported in the accompanying consolidated financial statements for current assets and current liabilities approximate the fair value because of the immediate or short-term maturities of the financial instruments. The valuation hierarchy is composed of three levels. The classification within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The levels within the valuation hierarchy are described below: Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. The fair values of financial assets of the Company were determined using the following categories at February 29, 2024 and February 28, 2023, respectively: Schedule of significant accounting policies - fair values of financial assets of the company Level 1 Level 2 Level 3 Total Marketable Securities – February 29, 2024 $ 9,711,351 $ — $ — $ 9,711,351 Marketable Securities – February 28, 2023 $ 7,361,000 $ 729,000 $ — $ 8,090,000 Marketable Securities include certificates of deposit and US Treasury securities, totaling $ 9,711,351 8,090,000
Income Taxes	Income Taxes no
Intangible Assets	Intangible Assets - 17 12 16,434 18,814 212,861 202,681 16,000
Inventories	Inventories -
Land and Buildings	Land and Buildings 40 At February 29, 2024 and February 28, 2023, the Company had Land, stated at cost of $ 250,000
Long-Lived Assets	Long-Lived Assets - No
Management Estimates	Management Estimates -
New Accounting Pronouncements	New Accounting Pronouncements Recent Accounting Pronouncements Not Yet Adopted Improvements to Income Tax Disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting
Product Warranty	Product Warranty
Research and Product Development Expenses	Research and Product Development Expenses - During fiscal 2024 and fiscal 2023, the Company spent approximately $ 2,886,000 2,149,000
Revenue Recognition	Revenue Recognition · Identification of the contract, or contracts, with a customer · Identification of the performance obligations in the contract · Determination of the transaction price · Allocation of the transaction price to the performance obligations in the contract · Recognition of revenue when, or as, performance obligations are satisfied
Stock-Based Compensation	Stock-Based Compensation ASC 718 requires the recognition of the fair value of stock compensation expense to be recognized over the vesting term of such award. The Company accounts for forfeitures as they occur.

SIGNIFICANT ACCOUNTING POLICI_3

SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Feb. 29, 2024
Accounting Policies [Abstract]
Schedule of significant accounting policies - fair values of financial assets of the company	The fair values of financial assets of the Company were determined using the following categories at February 29, 2024 and February 28, 2023, respectively: Schedule of significant accounting policies - fair values of financial assets of the company Level 1 Level 2 Level 3 Total Marketable Securities – February 29, 2024 $ 9,711,351 $ — $ — $ 9,711,351 Marketable Securities – February 28, 2023 $ 7,361,000 $ 729,000 $ — $ 8,090,000

REVENUE RECOGNITION (Tables)

REVENUE RECOGNITION (Tables)	12 Months Ended
	Feb. 29, 2024
Revenue Recognition
Schedule of revenue recognition - sales revenue by product line	The Company’s sales revenue, by product line is as follows: Schedule of revenue recognition - sales revenue by product line Twelve Months Ended February 29, February 28, 2024 % of total 2023 % of total Fluxing Systems $ 724,000 4% $ 1,179,000 8% Integrated Coating Systems 2,889,000 14% 1,114,000 7% Multi-Axis Coating Systems 10,075,000 51% 6,785,000 45% OEM Systems 1,533,000 8% 2,144,000 14% Other 4,479,000 23% 3,836,000 26% TOTAL $ 19,700,000 $ 15,058,000

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	12 Months Ended
	Feb. 29, 2024
Equity [Abstract]
Stock-based compensation - summary of stock options	A summary of the activity for both plans, for fiscal 2024 and fiscal 2023 is as follows: Stock-based compensation - summary of stock options Weighted Average Stock Options Exercise Price $ Remaining Outstanding Exercisable Outstanding Exercisable Term - Years Balance - February 28, 2022 253,710 61,690 $ 4.46 $ 3.53 8.94 Granted 44,739 5.71 Exercised (16,973 ) (1.77 ) Cancelled (30,717 ) (4.66 ) Balance - February 28, 2023 250,759 133,609 $ 4.84 $ 4.62 8.52 Granted 73,193 $ 5.02 Exercised (19,701 ) (3.62 ) Cancelled (8,709 ) (4.20 ) Balance - February 29, 2024 295,542 181,376 $ 4.99 $ 4.89 8.04
Schedule of weighted-average black-scholes assumptions	The weighted-average fair value of options has been estimated on the date of grant using the Black-Scholes options-pricing model. The weighted-average Black-Scholes assumptions are as follows: Schedule of weighted-average black-scholes assumptions Fiscal Year Ended February 29, February 28, Expected life 5 8 5 8 Risk free interest rate 2.82% 4.39% 2.82% 4.02% Expected volatility 55.02% 62.48% 55.02% 62.01% Expected dividend yield 0% 0%

INVENTORIES (Tables)

INVENTORIES (Tables)	12 Months Ended
	Feb. 29, 2024
Inventory Disclosure [Abstract]
Schedule of inventory, current	Inventories consist of the following: Schedule of inventory, current February 29, February 28, Raw materials and subassemblies $ 2,270,567 $ 1,868,689 Finished goods 1,785,952 613,915 Work in process 1,165,461 760,305 Total $ 5,221,980 $ 3,242,909

BUILDINGS, EQUIPMENT, FURNISH_2

BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Tables)	12 Months Ended
	Feb. 29, 2024
Property, Plant and Equipment [Abstract]
Buildings, equipment, furnishings and leasehold improvements	Buildings, equipment, furnishings and leasehold improvements consist of the following: Buildings, equipment, furnishings and leasehold improvements February 29, February 28, 2024 2023 Buildings $ 2,250,000 $ 2,250,000 Laboratory equipment 1,733,911 1,647,951 Machinery and equipment 1,891,345 1,807,817 Leasehold improvements 924,356 789,044 Tradeshow and demonstration equipment 1,151,899 1,137,346 Furniture and fixtures 1,771,084 1,302,545 Totals 9,722,595 8,934,703 Less: Accumulated depreciation (6,890,439 ) (6,309,707 ) $ 2,832,156 $ 2,624,996

ACCRUED EXPENSES (Tables)

ACCRUED EXPENSES (Tables)	12 Months Ended
	Feb. 29, 2024
Payables and Accruals [Abstract]
Accrued expenses	Accrued expenses consist of the following: Accrued expenses February 29, February 28, Accrued compensation $ 579,757 $ 352,619 Estimated warranty costs 524,875 500,650 Accrued sales tax 152,547 — Accrued commissions 133,771 157,927 Professional fees 74,826 100,921 Other accrued expenses 273,702 315,329 Total accrued expenses $ 1,739,478 $ 1,427,446

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Feb. 29, 2024
Income Tax Disclosure [Abstract]
Income taxes - income tax reconciliation	The annual provision (benefit) for income taxes differs from amounts computed by applying the maximum U.S. Federal income tax rate of 21% to pre-tax income as follows: Income taxes - income tax reconciliation February 29, February 28, Expected federal income tax $ 366,362 $ 165,882 State tax, net of federal 52,510 37,204 Research and development tax credits (161,525 ) (127,329 ) Permanent differences 45,770 78,252 Income tax expense $ 303,117 $ 154,009
Income taxes - current and deferred tax expense	Components of the current and deferred tax expense are as follows: Income taxes - current and deferred tax expense February 29, February 28, Current: Federal $ 716,003 $ 438,263 State 123,743 83,525 Total current income tax 839,746 521,788 Deferred: Federal (471,396 ) (321,458 ) State (65,233 ) (46,321 ) Total deferred income tax (536,629 ) (367,779 ) Income tax expense $ 303,117 $ 154,009
Income taxes - deferred tax asset and liability components	The deferred tax asset and liability are comprised of the following: Income taxes - deferred tax asset and liability components February 29, February 28, Deferred tax asset Allowance for inventory $ 91,000 $ 76,000 Allowance for accounts receivable 3,000 3,000 Capitalized R&D expenses – IRC Section 174 985,000 441,000 Accrued expenses and other 177,000 147,000 Deferred tax asset – Long Term $ 1,256,000 $ 667,000 Deferred tax liability Building and leasehold depreciation (230,000 ) (83,000 ) Deferred tax liability – Long Term $ (230,000 ) $ (83,000 )

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	12 Months Ended
	Feb. 29, 2024
Earnings Per Share [Abstract]
Schedule of computation of basic and diluted earnings per share	The following table sets forth the computation of basic and diluted earnings per share: Schedule of computation of basic and diluted earnings per share February 29, February 28, Numerator for basic and diluted earnings per share $ 1,441,463 $ 635,905 Denominator for basic earnings per share - weighted average 15,743,763 15,735,451 Effects of dilutive securities: Stock options for employees, directors and outside consultants 30,244 34,048 Denominator for diluted earnings per share 15,774,007 15,769,499 Basic Earnings Per Share – Weighted Average $ 0.09 $ 0.04 Diluted Earnings Per Share – Weighted Average $ 0.09 $ 0.04

CUSTOMER CONCENTRATIONS AND F_2

CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Tables)	12 Months Ended
	Feb. 29, 2024
Risks and Uncertainties [Abstract]
Schedule of customer concentrations and foreign sales	Export sales to customers located outside the United States and Canada were approximately as follows: Schedule of customer concentrations and foreign sales February 29, February 28, Asia Pacific (APAC) 3,268,000 3,260,000 Europe, Middle East, Asia (EMEA) 4,333,000 3,448,000 Latin America 1,221,000 1,546,000 $ 8,822,000 $ 8,254,000

Schedule of significant account

Schedule of significant accounting policies - fair values of financial assets of the company (Details) - USD ($)	Feb. 29, 2024	Feb. 28, 2023
Platform Operator, Crypto Asset [Line Items]
Marketable Securities	$ 9,711,351	$ 8,090,000
Fair Value, Inputs, Level 1 [Member]
Platform Operator, Crypto Asset [Line Items]
Marketable Securities	9,711,351	7,361,000
Fair Value, Inputs, Level 2 [Member]
Platform Operator, Crypto Asset [Line Items]
Marketable Securities		729,000
Fair Value, Inputs, Level 3 [Member]
Platform Operator, Crypto Asset [Line Items]
Marketable Securities

SIGNIFICANT ACCOUNTING POLICI_4

SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	12 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Property, Plant and Equipment [Line Items]
Advertising expense	$ 371,000	$ 297,500
Cash in excess of the FDIC insured limit	$ 1,819,000
Estimated useful lives	40 years
Marketable securities	$ 9,711,351	8,090,000
Uncertain tax positions	0	0
Amortization expense	16,434	18,814
Finite-Lived Intangible Assets, Accumulated Amortization	212,861	202,681
Finite-Lived Intangible Asset, Expected Amortization, Year Five	16,000
Land	250,000	250,000
Impairment losses	0	0
Research and development expenses	$ 2,886,000	$ 2,149,000
Domestic Patents [Member]
Property, Plant and Equipment [Line Items]
Finite-Lived Intangible Asset, Useful Life	17 years
Foreign Patents [Member]
Property, Plant and Equipment [Line Items]
Finite-Lived Intangible Asset, Useful Life	12 years
Equipment and Furnishings [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years
Equipment and Furnishings [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	5 years

Schedule of revenue recognition

Schedule of revenue recognition - sales revenue by product line (Details) - USD ($)	12 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Sales revenue	$ 19,699,886	$ 15,058,203
Fluxing Systems [Member]
Sales revenue	$ 724,000	$ 1,179,000
Sales revenue, percent	4%	8%
Integrated Coating Systems [Member]
Sales revenue	$ 2,889,000	$ 1,114,000
Sales revenue, percent	14%	7%
Multi Axis Coating Systems [Member]
Sales revenue	$ 10,075,000	$ 6,785,000
Sales revenue, percent	51%	45%
Oem Systems [Member]
Sales revenue	$ 1,533,000	$ 2,144,000
Sales revenue, percent	8%	14%
Other Product Line [Member]
Sales revenue	$ 4,479,000	$ 3,836,000
Sales revenue, percent	23%	26%
Total Product Line [Member]
Sales revenue	$ 19,700,000	$ 15,058,000

REVENUE RECOGNITION (Details Na

REVENUE RECOGNITION (Details Narrative) - USD ($)	12 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Revenue Recognition
Cash deposits	$ 3,420,000	$ 2,838,000
Letter of credit	72,000	145,000
Line of credit collateral amount	$ 72,000	$ 145,000

Stock-based compensation - summ

Stock-based compensation - summary of stock options (Details) - $ / shares	12 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 28, 2022
Equity [Abstract]
Stock Options outstanding at beginning of period (in shares)	250,759	253,710
Stock Options exercisable at beginning of period (in shares)	133,609	61,690
Weighted Average outstanding at beginning of period (in dollars per share)	$ 4.84	$ 4.46
Weighted Average exercisable at beginning of period (in dollars per share)	$ 4.62	$ 3.53
Weighted average remaining term outstanding	8 years 14 days	8 years 6 months 7 days	8 years 11 months 8 days
Granted (in shares)	73,193	44,739
Granted (in dollars per share)	$ 5.02	$ 5.71
Exercised (in shares)	(19,701)	(16,973)
Exercised (in dollars per share)	$ (3.62)	$ (1.77)
Cancelled (in shares)	(8,709)	(30,717)
Cancelled (in dollars per share)	$ (4.20)	$ (4.66)
Stock Options outstanding at end of period (in shares)	295,542	250,759	253,710
Stock Options exercisable at end of period (in shares)	181,376	133,609	61,690
Weighted Average outstanding at end of period (in dollars per share)	$ 4.99	$ 4.84	$ 4.46
Weighted Average exercisable at end of period (in dollars per share)	$ 4.89	$ 4.62	$ 3.53

Schedule of weighted-average bl

Schedule of weighted-average black-scholes assumptions (Details)	12 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk free interest rate, minimum	2.82%	2.82%
Risk free interest rate, maximum	4.39%	4.02%
Expected volatility, minimum	55.02%	55.02%
Expected volatility, maximum	62.48%	62.01%
Expected dividend yield	0%	0%
Share-Based Payment Arrangement, Option [Member] | Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected life (in years)	5 years	5 years
Share-Based Payment Arrangement, Option [Member] | Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected life (in years)	8 years	8 years

STOCK-BASED COMPENSATION (Detai

STOCK-BASED COMPENSATION (Details Narrative) - USD ($)	12 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 28, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options outstanding	295,542	250,759	253,710
Options granted	73,193	44,739
Options, exercisable price	$ 5.02	$ 5.71
Aggregate intrinsic value of options outstanding	$ 167,709
Stock-based compensation expense	203,577	$ 256,740
Compensation expense not yet recognized	$ 298,000
Compensation expense, period for recognition	3 years
Options cancelled in settlement of shares issued	8,807
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options granted	54,813	28,239
Share-Based Payment Arrangement, Option [Member] | Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options, exercisable price	$ 4.79	$ 5.45
Share-Based Payment Arrangement, Option [Member] | Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options, exercisable price	$ 5.60	$ 5.96
Non-Employee Directors [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options granted	18,380	16,500
Options, exercisable price	$ 4.79	$ 5.50
Employee and Directors [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options, expiration period	10 years	10 years
Options, vesting period	3 years	3 years
Weighted average grant date fair value, per share	$ 3.11	$ 3.44
the “2023 Plan” [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares available for purchase	2,500,000
Options outstanding	65,793
Options granted	2,500,000
Options, expiration period	10 years
the "2013 Plan" [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options outstanding	229,749

Schedule of inventory, current

Schedule of inventory, current (Details) - USD ($)	Feb. 29, 2024	Feb. 28, 2023
Inventory Disclosure [Abstract]
Raw materials and subassemblies	$ 2,270,567	$ 1,868,689
Finished goods	1,785,952	613,915
Work in process	1,165,461	760,305
Total	$ 5,221,980	$ 3,242,909

INVENTORIES (Details Narrative)

INVENTORIES (Details Narrative) - USD ($)	Feb. 29, 2024	Feb. 28, 2023
Inventory Disclosure [Abstract]
Allowance for slow moving inventory	$ 380,400	$ 332,525

Buildings, equipment, furnish_3

Buildings, equipment, furnishings and leasehold improvements (Details) - USD ($)	Feb. 29, 2024	Feb. 28, 2023
Property, Plant and Equipment [Line Items]
Totals	$ 9,722,595	$ 8,934,703
Less: Accumulated depreciation	(6,890,439)	(6,309,707)
Equipment, furnishings and leasehold improvements, net	2,832,156	2,624,996
Building [Member]
Property, Plant and Equipment [Line Items]
Totals	2,250,000	2,250,000
Laboratory Equipment [Member]
Property, Plant and Equipment [Line Items]
Totals	1,733,911	1,647,951
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Totals	1,891,345	1,807,817
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Totals	924,356	789,044
Tradeshow And Demonstration Equipment [Member]
Property, Plant and Equipment [Line Items]
Totals	1,151,899	1,137,346
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Totals	$ 1,771,084	$ 1,302,545

BUILDINGS, EQUIPMENT, FURNISH_4

BUILDINGS, EQUIPMENT, FURNISHINGS AND LEASEHOLD IMPROVEMENTS (Details Narrative) - USD ($)	12 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Property, Plant and Equipment [Abstract]
Depreciation Expense	$ 580,732	$ 492,055

Accrued expenses (Details)

Accrued expenses (Details) - USD ($)	Feb. 29, 2024	Feb. 28, 2023
Payables and Accruals [Abstract]
Accrued compensation	$ 579,757	$ 352,619
Estimated warranty costs	524,875	500,650
Accrued sales tax	152,547
Accrued commissions	133,771	157,927
Professional fees	74,826	100,921
Other accrued expenses	273,702	315,329
Total accrued expenses	$ 1,739,478	$ 1,427,446

REVOLVING LINE OF CREDIT (Detai

REVOLVING LINE OF CREDIT (Details Narrative) - USD ($)	Feb. 29, 2024	Feb. 28, 2023
Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Revolving line of credit	$ 1,500,000	$ 1,500,000
Interest rate	8.50%	7.75%
Letter of Credit [Member]
Line of Credit Facility [Line Items]
Credit line utilized to collateralize letter of credit issued to customers	$ 72,000	$ 145,000
Unused portion of credit line	$ 1,428,000	$ 1,355,000

Income taxes - income tax recon

Income taxes - income tax reconciliation (Details) - USD ($)	12 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Income Tax Disclosure [Abstract]
Income tax expense	$ 303,117	$ 154,009

Income taxes - current and defe

Income taxes - current and deferred tax expense (Details) - USD ($)	12 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Current:
Federal	$ 716,003	$ 438,263
State	123,743	83,525
Total current income tax	839,746	521,788
Federal	(471,396)	(321,458)
State	(65,233)	(46,321)
Total deferred income tax	(536,629)	(367,779)
Income tax expense	$ 303,117	$ 154,009

Income taxes - deferred tax ass

Income taxes - deferred tax asset and liability components (Details) - USD ($)	Feb. 29, 2024	Feb. 28, 2023
Income Tax Disclosure [Abstract]
Allowance for inventory	$ 91,000	$ 76,000
Allowance for accounts receivable	3,000	3,000
Capitalized R&D expenses - IRC Section 174	985,000	441,000
Accrued expenses and other	177,000	147,000
Deferred tax asset - Long Term	1,256,000	667,000
Building and leasehold depreciation	(230,000)	(83,000)
Deferred tax liability - Long Term	$ (230,000)	$ (83,000)

Schedule of computation of basi

Schedule of computation of basic and diluted earnings per share (Details) - USD ($)	12 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Earnings Per Share [Abstract]
Numerator for basic and diluted earnings per share	$ 1,441,463	$ 635,905
Denominator for basic earnings per share - weighted average	15,743,763	15,735,451
Effects of dilutive securities:
Stock options for employees, directors and outside consultants	30,244	34,048
Denominator for diluted earnings per share	15,774,007	15,769,499
Basic Earnings Per Share – Weighted Average	$ 0.09	$ 0.04
Diluted Earnings Per Share – Weighted Average	$ 0.09	$ 0.04

Schedule of customer concentrat

Schedule of customer concentrations and foreign sales (Details) - USD ($)	12 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Total sales	$ 8,822,000	$ 8,254,000
Asia Pacific [Member]
Total sales	3,268,000	3,260,000
Middle East [Member]
Total sales	4,333,000	3,448,000
Latin America [Member]
Total sales	$ 1,221,000	$ 1,546,000

CUSTOMER CONCENTRATIONS AND F_3

CUSTOMER CONCENTRATIONS AND FOREIGN SALES (Details Narrative) - USD ($)	12 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Concentration Risk [Line Items]
Sales revenue	$ 19,699,886	$ 15,058,203
Revenue Benchmark [Member] | Foreign Customers [Member]
Concentration Risk [Line Items]
Sales revenue	$ 8,822,000	$ 8,254,000
Sales revenue, percent	45%	55%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Concentration Risk [Line Items]
Outstanding accounts receivables, percent		14%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Concentration Risk [Line Items]
Outstanding accounts receivables, percent	26%	28%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Four Customers [Member]
Concentration Risk [Line Items]
Outstanding accounts receivables, percent		44%